Results 181 to 190 of about 506,772 (307)

Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis. [PDF]

open access: yesMayo Clin Proc Innov Qual Outcomes
Ishiuji Y   +13 more
europepmc   +1 more source

Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This analysis used a large clinical trial data set (>30,000 patient visits across >2800 patients) and novel statistical methodologies (including frequency cross‐over analysis and means based on spline regression) to develop severity threshold bands for clinician‐ and patient‐reported outcome measures for adults with moderate‐to‐severe atopic dermatitis.
Andreas Wollenberg   +7 more
wiley   +1 more source

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

The prose poem [PDF]

open access: yes, 2004
Miller, D
core  

Randomised controlled trial of mānuka oil-based ECMT-154™ vs. vehicle control for the topical treatment of eczema, conducted in community pharmacies in New Zealand. [PDF]

open access: yesBMC Complement Med Ther
Shortt G   +12 more
europepmc   +1 more source

Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review assessed 52 biomarkers predicting systemic therapy response and adverse events in atopic dermatitis. Most studies focused on dupilumab, and findings were inconsistent. IgE and eosinophils were largely non‐predictive, though elevated eosinophils and LDH sometimes indicated poorer outcomes.
Eva Hilger   +11 more
wiley   +1 more source

Rann [Hindi]

open access: yesResearch and Humanities in Medical Education, 2020
Medha Mathur
doaj  

Comprehensive evaluation of current strategies in achalasia treatment: Insights from an umbrella review. [PDF]

open access: yesMedicine (Baltimore)
Letafatkar N   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy